A three-drug combination worked better than any of them alone in treating ALS caused by mutations in the SOD1 gene, per a new ...

RAG-17 therapy slowed functional decline and stabilized or improved breathing in people with ALS who carry mutations in the SOD1 gene.

A team of researchers from the University of Wollongong (UOW) have discovered that a unique trio of medications could hold ...

A genetic test confirmed it the following October: Morris had ALS – just like 22 other people in her family with the ...

Researchers build on work of renowned academic Professor Justin Yerbury A team of researchers from the University of Wollongong (UOW) have ...

There was slightly better news from Biogen’s tofersen, an investigational molecule for amyotrophic lateral sclerosis caused by a mutated superoxide dismutase 1 (SOD1) gene. A phase 3 trial is ...

Though SOD1 mutations are associated with fewer than ... Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59–62 (1993).

associated with a mutation in the SOD1 gene. The drug – branded as Qalsody – is the first therapy to be approved for a genetic form of ALS, and is also notable for being the first neurology ...

While the treatment only applies to patients with a subtype of MND caused by a faulty SOD1 gene (approximately 2 per cent of all MND patients) this work has the potential to change the future of ...

While the treatment only applies to patients with a subtype of MND caused by a faulty SOD1 gene (approximately 2 per cent of all MND patients) this work has the potential to change the future of ...